poisar

Stocks · News reference

BTIG Raises Docusign Price Target to $90.00

Fiscal.ai

BTIG has increased its price target for Docusign, Inc. from $75.00 to $90.00 per share.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolBrendan Coffey

    Docusign vs. Fastly: Which Technology Stock Is a Better Buy for 2027?

    The article compares Docusign and Fastly as investment options for 2027. Docusign, a mature digital agreement platform with 1.8 million customers, shows steady 8.6% revenue growth and profitability but faces market saturation and AI competition. Fastly, an edge computing platform, demonstrates faster 21.5% revenue growth and processes 5 trillion daily requests despite current losses. The analyst recommends Fastly as the better buy due to its superior growth trajectory and large addressable market, despite a higher forward P/E valuation.

  2. The Motley FoolBrendan Coffey

    Axon Enterprise vs. DocuSign: Which Industrials Stock Is a Better Buy in 2026?

    Axon Enterprise and DocuSign represent different investment profiles: Axon offers faster growth (33.5% revenue growth) in public safety technology with a premium valuation (49.8x forward P/E), while DocuSign provides steadier cash generation (8.2% revenue growth) at a more reasonable valuation (16.6x forward P/E). Despite Axon's impressive growth prospects, the article recommends DocuSign for 2026 due to its more attractive valuation and reasonable forward multiples.

  3. The Motley FoolJohn Ballard

    Arista Networks vs. DocuSign: Which Tech Stock Is the Better Buy in 2026?

    The article compares Arista Networks and DocuSign as investment options for 2026. Arista dominates AI infrastructure networking with 33% YoY revenue growth and strong margins, while DocuSign provides agreement management software with more modest 9% growth. The author recommends Arista despite higher valuations, citing accelerating demand, tripled purchase commitments, and expected 40% revenue growth versus DocuSign's single-digit growth.